Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $53.39 USD
Change Today -1.29 / -2.36%
Volume 2.8M
NVO On Other Exchanges
Symbol
Exchange
OTC US
Copenhagen
New York
Mexico
Frankfurt
As of 8:04 PM 03/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Kåre Schultz

President, Chief Operating Officer and Member of Executive Management, Novo Nordisk A/S
AgeTotal Calculated CompensationThis person is connected to 21 board members in 2 different organizations across 3 different industries.

See Board Relationships
53kr11,700,000
As of Fiscal Year 2013

Background*

Mr. Kåre Schultz has been the President and Chief Operating Officer of Novo Nordisk A/S since January 30, 2014 & March 2002 respectively. Mr. Schultz also serves as Member of Executive Management of Novo Nordisk A/S. Mr. Schultz served as an Executive Vice President of Novo Nordisk A/S from November 2011 to January 2014. He joined Novo Nordisk A/S in 1989 as an Economist in Health Care, Economy and Planning and since November 2000, he served as its Chief of Staff and ...

Read Full Background

Corporate Headquarters*

Novo Allé
Bagsvaerd, Capital Region of Denmark 2880

Denmark

Phone: 45 44 44 88 88
Fax: 45 44 49 05 55

Board Members Memberships*

2007-Present
Member of The Board
2010-Present
Chairman, Chairman of Remuneration Committee and Chairman of Nomination Committee

Education*

MS 1987
Københavns Universitet

Other Affiliations*

Annual Compensation*

Salarykr6,300,000
Bonuskr2,700,000
Total Annual Compensationkr9,000,000

Stock Options*

All Other Compensationkr2,700,000

Total Compensation*

Total Annual Cash Compensationkr11,700,000
Total Short Term Compensationkr9,000,000
Other Long Term Compensationkr2,700,000
Total Calculated Compensationkr11,700,000
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NVO:US $53.39 USD -1.29

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Robert A. Bradway Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee
Amgen Inc.
$1.5M
Lamberto Andreotti Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee
Bristol-Myers Squibb Company
$1.7M
George A. Scangos Ph.D.Chief Executive Officer and Director
Biogen Inc.
$1.5M
Brenton L. Saunders J.D.Chief Executive Officer, President and Director
Actavis plc
--
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
$1.6M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOVO-NORDISK A/S-SPONS ADR, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.